Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

71.96
-1.2900-1.76%
Volume:328.45K
Turnover:23.88M
Market Cap:1.65B
PE:15.85
High:74.99
Open:73.54
Low:71.56
Close:73.25
52wk High:99.50
52wk Low:70.15
Shares:22.97M
Float Shares:20.28M
Volume Ratio:0.81
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.77
PE(LYR):21.67

Loading ...

Aug 26, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 24, 2026

Major Issues Report

Form 8-K - Current report
Aug 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2026

Major Issues Report

Form 8-K - Current report
Jul 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 28, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 17, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2026

Major Issues Report

Form 8-K - Current report
May 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2026

Major Issues Report

Form 8-K - Current report
May 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2026

Major Issues Report

Form 8-K - Current report
May 08, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 07, 2026

Major Issues Report

Form 8-K - Current report
Mar 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities